P.R. Herzig & Co’s AbbVie ABBV Stock Holding History

P.R. Herzig & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,600	Closed	-$269K	–	47
2015 Q1	$269K	Buy	+4,600	New	+$278K	0.46%	46

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

P.R. Herzig & Co's ABBV Position: Q2 2015 in Review

P.R. Herzig & Co sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 4,600 shares — an estimated $269K sold.

P.R. Herzig & Co first reported a position in ABBV in Q1 2015 and held it in 1 quarter. The position peaked at $269K in Q1 2015. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

P.R. Herzig & Co reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
P.R. Herzig & Co sold 4,600 AbbVie shares in Q2 2015, an estimated $269K.
P.R. Herzig & Co first reported a position in AbbVie in Q1 2015 and held it in 1 quarter.
P.R. Herzig & Co's AbbVie position peaked at $269K in Q1 2015.
1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on P.R. Herzig & Co's 13F filing for Q2 2015, filed 10 Jul 2015.